Cyclica is the partner of choice for data-driven drug discovery. We advance molecules that embrace the complexity of the disease.

Our computational approach to polypharmacology is unique in the industry. We use a proteome-wide lens to evaluate multiple novel and rare on- and off-target interactions simultaneously. We’re the only company of our kind that integrates scientific fields to advance molecules further down the pipeline. A structure-based view keeps our work accountable to biology, chemistry, physics, and genomics.

For our large biotech and pharma customers, we help enrich existing portfolios, building custom models that deliver IP-grade, proprietary insights with breakthrough efficiency and precision. Separately, across a portfolio of more than 50 drug discovery programs, collaborations, joint ventures and growing, we work at the vanguard of a wide variety of therapeutic areas to help get new medicines to patients faster and more precisely.

Cyclica logo



Event details

Date: May 11 - 13, 2021

Event contact

Jill MacLean
Area Director
Africa and Israel


11 in total